Demant EBITDA 2012-2024 | WILYY

Demant EBITDA for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.

  • Demant 2024 EBITDA was 0.671B, a 16.76% decline from 2023.
  • Demant 2023 EBITDA was 0.806B, a 26.35% increase from 2022.
  • Demant 2022 EBITDA was 0.638B, a 13.79% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Demant EBITDA 2012-2024 | WILYY

  • Demant 2024 EBITDA was 0.671B, a 16.76% decline from 2023.
  • Demant 2023 EBITDA was 0.806B, a 26.35% increase from 2022.
  • Demant 2022 EBITDA was 0.638B, a 13.79% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$228.8B
Boston Scientific (BSX)$153.1B
Stryker (SYK)$149.1B
EssilorLuxottica (ESLOY)$130.1B
Medtronic (MDT)$114.4B
Lonza Group Ag (LZAGY)$49.2B
Haleon (HLN)$43.7B
ResMed (RMD)$37B
GE HealthCare Technologies (GEHC)$34.1B
Agilent Technologies (A)$32.1B
Terumo (TRUMY)$24.2B
Koninklijke Philips (PHG)$23.2B
Insulet (PODD)$20.4B
Zimmer Biomet Holdings (ZBH)$18.6B
Baxter (BAX)$14.5B
Smith & Nephew SNATS (SNN)$12.8B
Sunny Optical Technology (SNPTF)$8.6B
Bio-Rad Laboratories (BIO)$6.7B
Lantheus Holdings (LNTH)$5.6B
Perrigo (PRGO)$3.7B
Prestige Consumer Healthcare (PBH)$3.7B
Haemonetics (HAE)$3.6B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
ICU Medical (ICUI)$3.1B
QuidelOrtho (QDEL)$1.9B
LeMaitre Vascular (LMAT)$1.9B
AtriCure (ATRC)$1.5B
Acuren (TIC)$1.4B
Green Thumb Industries (GTBIF)$1.2B